Summary of Changes for May 2018

This page contains information on changes to the MBS that occurred during May 2018.

Page last updated: 23 November 2020

Summary of Item Changes



New Items
11728, 32528, 32529, 38288, 42652, 61647, 63395, 63396, 63397, 63398, 63547, 63548,
    Amended Descriptors
    15565, 30481, 30482, 30483, 34103, 32520, 32522, 32523, 32526

    New Note
    TN.8.136

    Amended Notes
    TN.8.2, TN.8.33, IN.0.18, IN.0.13

    New cardiac items for diagnosis of atrial fibrillation in patients with embolic stroke of undetermined source
    A new cardiac service for the diagnosis of atrial fibrillation in patients with embolic stroke of undetermined source, involving a new item for the insertion of implantable loop recorders (ILR), and another for investigation of the inserted ILR.

    Amendment to item 15565 for preparation of an intensity modulated radiotherapy (IMRT) dosimetry plan
    On 1 May 2018, item 15565 will be amended to reflect developments in the methodology for dosimetric checks by removing references to the use of a dosimetric phantom.

    Amended descriptors for gastrostomy items 30481, 30482 and 39483
    This change amends existing gastrostomy items 30481, 30482 and 30483 (for patients who require long term enteral feeding/nutrient support) to prevent the items from being claimed in association with the insertion of experimental weight loss surgical devices.

    Amendments made to items 32520,32522,32523 and 32526 to include reference to cyanoacrylate embolisation
    Items 32520, 32522,32523 and 32526 have been amended to include reference to the new service,cyanoacrylate embolisation for the treatment of varicose veins due to chronic venous insufficiency.

    Cyanoacrylate embolisation (CAE) for the treatment of chronic varicose veins
    An alternative service to radio frequency ablation (RFA) and endovenous laser therapy (ELT) services for the treatment of varicose veins due to chronic venous insufficiency.

    New cardiac items for diagnosis of atrial fibrillation in patients with embolic stroke of undetermined source
    A new cardiac service for the diagnosis of atrial fibrillation in patients with embolic stroke of undetermined source, involving a new item for the insertion of implantable loop recorders (ILR), and another for investigation of the inserted ILR.

    Corneal Collagen Cross Linking
    New MBS Item for Corneal Collagen Cross Linking

    Magnetic resonance imaging (MRI) of the cardiovascular system
    Four new items (two K items and two NK items) have been introduced for magnetic resonance imaging (MRI) of the cardiovascular system for the diagnosis of arrthymogenic right ventricular cardiomyopathy (ARVC) for patients who have presented with symptoms or investigative findings consistent with ARVC or are asymptomatic with a family history of confirmed ARVC.

    Magnetic resonance imaging (MRI) of the breasts
    Two new items (K and NK) have been introduced for magnetic resonance imaging (MRI) of the breasts for patients diagnosed with breast-implant-associated anaplastic large cell lymphoma to assist with surgical planning.

    Whole body 68Ga-DOTA-peptide Positron Emission Tomography (PET) study
    A new item has been introduced for Whole body 68GA-DOTA peptide PET study, including any associated computed tomography scans for anatomic localisation or attenuation correction, if:
    (a) a gastro-entero-pancreatic neuroendocrine tumour is suspected on the basis of biochemical evidence with negative or equivocal conventional imaging; or
    (b) a surgically amenable gastro-entero-pancreatic neuroendocrine tumour has been identified on the basis of conventional techniques, in order to exclude additional disease sites.